Skip to main content

Table 2 Summary of diagnostic work-up at initial diagnosis, RTx treatment (target dose, RTx duration, time between start of induction chemotherapy (iCTx) and RTx start, mean lung dose, lung V20 and mean heart dose) and sequence of systemic therapy

From: Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

  Absolute Percentage (%)
Staging and clinical work-up
Computed Tomography (CT) 46 100.0
[18F]FDG positron-emission-tomography/ computed-tomography (PET/CT) 41 89.1
Endobronchial Ultrasound Bronchoscopy (EBUS)/ Endoscopic Ultrasound with Bronchoscope (EUS-B) 19 41.3
Rigid bronchoscopy 46 100.0
Mediastinoscopy 28 60.9
Radiotherapy (RTx) Mean Range
Target dose
Gy
67.6 60.0–71.0
RTx duration
days (approx.)
44.5 31–115
Time between iCTx start and RTx start
days
79.7 20–150.4
Mean lung dose
Gy
14.4 10.4–18.9
Lung V20
%
23.9 6.8–32
Mean heart dose Gy 10.4 1.6–28.6
Systemic agents Absolute Percentage (%)
Induction chemotherapy 46 100.0
Concurrent chemotherapy 46 100.0
Adjuvant immunotherapy 8 17.4
Total 46 pts 100%